Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1986 Oct;78(4):874–879. doi: 10.1172/JCI112674

T lymphocyte cloning from rejected human kidney allografts. Growth frequency and functional/phenotypic analysis.

J F Moreau, M Bonneville, M A Peyrat, A Godard, Y Jacques, C Desgranges, J P Soulillou
PMCID: PMC423705  PMID: 3020092

Abstract

Mechanically harvested lymphocytes invading an irreversibly rejected human kidney allograft were seeded at limiting dilution to calculate the frequency of growing precursors. Optimal growth frequency (1/13) was obtained when Epstein-Barr virus (EBV)-transformed donor B lymphocytes were used as stimulators (D-BLCL) in the presence of interleukin 2 (IL-2). The 55 clones analyzed were all T11+ and T3+, and all expressed DR antigens (45% were T8+ and 55% T4+). Only one clone had a double-labeled (T4+ T8+) surface. All cells proliferated significantly against D-BLCL, although T4+ clones had a significantly shorter average doubling time than T8+ clones. Nearly all T8+ clones were specifically cytotoxic for D-BLCL, while both T4 and T8 did not react against K562, autologous EBV-BLCL, and third-party EBV-BLCL. Detectable IL-2 was found in the culture supernatants of only a minority of clones (all T4+).

Full text

PDF
874

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnold A., Lipkowitz S., Suthanthiran M., Novogrodsky A., Stenzel K. H. Human B lymphoblastoid cell lines provide an interleukin 1-like signal for mitogen-treated T lymphocytes via direct cell contact. J Immunol. 1985 Jun;134(6):3876–3881. [PubMed] [Google Scholar]
  2. Ascher N. L., Chen S., Hoffman R. A., Simmons R. L. Maturation of cytotoxic T cells within sponge matrix allografts. J Immunol. 1983 Aug;131(2):617–621. [PubMed] [Google Scholar]
  3. Ascher N. L., Hoffman R., Hanto D. W., Simmons R. L. Cellular events within the rejecting allograft. Transplantation. 1983 Mar;35(3):193–197. [PubMed] [Google Scholar]
  4. First French workshop on standardization of human IL-2: joint report. Lymphokine Res. 1982;1(4):121–127. [PubMed] [Google Scholar]
  5. Godard A., Naulet J., Peyrat M. A., Vie H., Moreau J. F., Bignon J. D., Soulillou J. P. Preparative two-step purification of human IL-2 by HPLC and hydrophobic affinity chromatography. J Immunol Methods. 1984 May 25;70(2):233–244. doi: 10.1016/0022-1759(84)90188-1. [DOI] [PubMed] [Google Scholar]
  6. Hancock W. W., Thomson N. M., Atkins R. C. Composition of interstitial cellular infiltrate identified by monoclonal antibodies in renal biopsies of rejecting human renal allografts. Transplantation. 1983 May;35(5):458–463. doi: 10.1097/00007890-198305000-00013. [DOI] [PubMed] [Google Scholar]
  7. Häyry P., von Willebrand E. Transplant aspiration cytology. Transplantation. 1984 Jul;38(1):7–12. doi: 10.1097/00007890-198407000-00002. [DOI] [PubMed] [Google Scholar]
  8. Immunosuppression. Cyclosporine. Transplant Proc. 1985 Feb;17(1 Pt 2):1158–1290. [PubMed] [Google Scholar]
  9. Loveland B. E., Hogarth P. M., Ceredig R., McKenzie I. F. Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection. J Exp Med. 1981 May 1;153(5):1044–1057. doi: 10.1084/jem.153.5.1044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Manca F., Barocci S., Kunkl A., Gurreri G., Costantini M., Celada F. Recognition of donor fibroblast antigens by lymphocytes homing in the human grafted kidney. Transplantation. 1983 Dec;36(6):670–674. doi: 10.1097/00007890-198336060-00017. [DOI] [PubMed] [Google Scholar]
  11. Mayer T. G., Fuller A. A., Fuller T. C., Lazarovits A. I., Boyle L. A., Kurnick J. T. Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection. J Immunol. 1985 Jan;134(1):258–264. [PubMed] [Google Scholar]
  12. Meuer S. C., Hodgdon J. C., Cooper D. A., Hussey R. E., Fitzgerald K. A., Schlossman S. F., Reinherz E. L. Human cytotoxic T cell clones directed at autologous virus-transformed targets: further evidence for linkage of genetic restriction to T4 and T8 surface glycoproteins. J Immunol. 1983 Jul;131(1):186–190. [PubMed] [Google Scholar]
  13. Meuer S. C., Hussey R. E., Cantrell D. A., Hodgdon J. C., Schlossman S. F., Smith K. A., Reinherz E. L. Triggering of the T3-Ti antigen-receptor complex results in clonal T-cell proliferation through an interleukin 2-dependent autocrine pathway. Proc Natl Acad Sci U S A. 1984 Mar;81(5):1509–1513. doi: 10.1073/pnas.81.5.1509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Miller G., Shope T., Lisco H., Stitt D., Lipman M. Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. Proc Natl Acad Sci U S A. 1972 Feb;69(2):383–387. doi: 10.1073/pnas.69.2.383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Moreau J. F., Miller R. G. Growth at limiting dilution of human T cell colonies from T cell-depleted peripheral blood leukocytes. J Immunol. 1983 Mar;130(3):1139–1145. [PubMed] [Google Scholar]
  16. Moreau J. F., Peyrat M. A., Vie H., Bonneville M., Soulillou J. P. T cell colony-forming frequency of mononucleated cells extracted from rejected human kidney transplants. Functional and phenotypic studies of the colonies. Transplantation. 1985 Jun;39(6):649–656. doi: 10.1097/00007890-198506000-00015. [DOI] [PubMed] [Google Scholar]
  17. Platt J. L., LeBien T. W., Michael A. F. Interstitial mononuclear cell populations in renal graft rejection. Identification by monoclonal antibodies in tissue sections. J Exp Med. 1982 Jan 1;155(1):17–30. doi: 10.1084/jem.155.1.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Roth D., Fuller L., Esquenazi V., Kyriakides G. K., Pardo V., Miller J. The biologic significance of the mixed lymphocyte kidney culture in humans. Transplantation. 1985 Oct;40(4):376–383. doi: 10.1097/00007890-198510000-00007. [DOI] [PubMed] [Google Scholar]
  19. Steinmuller D. Which T cells mediate allograft rejection? Transplantation. 1985 Sep;40(3):229–233. doi: 10.1097/00007890-198509000-00001. [DOI] [PubMed] [Google Scholar]
  20. Strom T. B., Tilney N. L., Carpenter C. B., Busch G. J. Identity and cytotoxic capacity of cells infiltrating renal allografts. N Engl J Med. 1975 Jun 12;292(24):1257–1263. doi: 10.1056/NEJM197506122922402. [DOI] [PubMed] [Google Scholar]
  21. Strom T. B., Tilney N. L., Paradysz J. M., Bancewicz J., Carpenter C. B. Cellular components of allograft rejection: identity, specificity, and cytotoxic function of cells infiltrating acutely rejecting allografts. J Immunol. 1977 Jun;118(6):2020–2026. [PubMed] [Google Scholar]
  22. Tufveson G., Forsum U., Claesson K., Klareskog L., Larsson E., Karlsson-Parra A., Frödin L. T-lymphocyte subsets and HLA-DR-expressing cells in rejected human kidney grafts. Scand J Immunol. 1983 Jul;18(1):37–40. doi: 10.1111/j.1365-3083.1983.tb00833.x. [DOI] [PubMed] [Google Scholar]
  23. Van de Griend R. J., Van Krimpen B. A., Bol S. J., Thompson A., Bolhuis R. L. Rapid expansion of human cytotoxic T cell clones: growth promotion by a heat-labile serum component and by various types of feeder cells. J Immunol Methods. 1984 Feb 10;66(2):285–298. doi: 10.1016/0022-1759(84)90340-5. [DOI] [PubMed] [Google Scholar]
  24. Wilson C. B., Lehman D. H., McCoy R. C., Gunnells J. C., Jr, Stickel D. L. Antitubular basement membrane antibodies after renal transplantation. Transplantation. 1974 Nov;18(5):447–452. doi: 10.1097/00007890-197411000-00010. [DOI] [PubMed] [Google Scholar]
  25. van de Griend R. J., Bolhuis R. L. Rapid expansion of allospecific cytotoxic T cell clones using nonspecific feeder cell lines without further addition of exogenous IL2. Transplantation. 1984 Oct;38(4):401–406. doi: 10.1097/00007890-198410000-00017. [DOI] [PubMed] [Google Scholar]
  26. von Willebrand E. OKT4/8 ratio in the blood and in the graft during episodes of human renal allograft rejection. Cell Immunol. 1983 Apr 1;77(1):196–201. doi: 10.1016/0008-8749(83)90019-9. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES